A Phase IIa, Open-label, Multiple Ascending Dose Confirmation Study of the Safety and Tolerability of Intravenous Brincidofovir in Subjects with Adenovirus Infection
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
SymBio Pharmaceuticals Limited
Start Date
February 23, 2022
End Date
December 1, 2025
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
SymBio Pharmaceuticals Limited
Start Date
February 23, 2022
End Date
December 1, 2025